Article
CD95 antigen mutations in hematopoietic malignancies.
Leukemia & lymphoma - 1 Jan 2000
Landowski T H, Moscinski L, Burke R, Buyuksal I, Painter J S, Goldstein S, Dalton W S
Abstract excerpt
The CD95 receptor, also known as Fas/Apo-1, is a member of the Tumor Necrosis Factor receptor (TNF-R) family of death receptors. Apoptosis mediated by CD95 plays a central role in maintaining homeostasis of the immune system. Dysregulation of the CD95 apoptotic pathway has been proposed as a mechanism of oncogenesis by providing a survival advantage to potentially malignant cells. This extended lifespan could...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
